Company · ARQT
Arcutis Biotherapeutics, Inc.
Nasdaq's symbol directory lists ARQT on Nasdaq as “Arcutis Biotherapeutics, Inc. - Common stock”.
In the 12 months to Nov 8, 2026: insiders sold on 21 occasions ($4.2M); 8 planned-sale notices; 3 filings by holders of 5% or more; 3 congressional trade disclosures; 2 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Masaru Matsuda, EVP, Chief Legal Officer sold $1.8M
- Curran Terrie sold $984K
- Welgus Howard G. sold $609K
- Burnett Patrick, EVP, Chief Medical Officer sold $496K
- Watanabe Todd, Reporting Person's title: President and Chief Executive Officer sold $254K
- LIN SUE-JEAN sold $121K
Every trade (21)
- SELLMasaru Matsuda, EVP, Chief Legal Officer sold $1.4M
- SELLWatanabe Todd, Reporting Person's title: President and Chief Executive Officer sold $139K
- SELLMasaru Matsuda, EVP, Chief Legal Officer sold $39K
- SELLBurnett Patrick, EVP, Chief Medical Officer sold $30K
- SELLWelgus Howard G. sold $127K
- SELLMasaru Matsuda, Reporting Person's title: EVP, Chief Legal Officer sold $92K
- SELLWelgus Howard G. sold $114K
- SELLMasaru Matsuda, Reporting Person's title: EVP, Chief Legal Officer sold $250K
- SELLCurran Terrie sold $956K
- SELLCurran Terrie sold $28K
- SELLBurnett Patrick, Reporting Person's title: EVP, Chief Medical Officer sold $46K
- SELLWelgus Howard G. sold $124K
- SELLBurnett Patrick, Reporting Person's title: EVP, Chief Medical Officer sold $175K
- SELLBurnett Patrick, Reporting Person's title: EVP, Chief Medical Officer sold $220K
- SELLWatanabe Todd, Reporting Person's title: President and Chief Executive Officer sold $114K
- SELLMasaru Matsuda, Reporting Person's title: EVP, Chief Legal Officer sold $32K
- SELLBurnett Patrick, Reporting Person's title: EVP, Chief Medical Officer sold $25K
- SELLWelgus Howard G. sold $127K
- SELLWelgus Howard G. sold $16K
- SELLLIN SUE-JEAN sold $121K
- SELLWelgus Howard G. sold $100K
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- Masaru Matsuda $1.4M
- Todd Franklin Watanabe $139K
- Masaru Matsuda $39K
- Patrick Burnett $30K
- Larry Todd Edwards $2.0M
- Howard Welgus $127K
- Larry Todd Edwards $8.5M
- Howard Welgus $114K
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- BlackRock, Inc. 14.1%
- Polar Capital Holdings Plc 5.28%
- STATE STREET CORPORATION 4.7%
Congress · STOCK Act
The Althing
Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.
- Gilbert Cisneros (D-CA31): Purchase $1,001 - $15,000
- Gilbert Cisneros (D-CA31): Purchase $1,001 - $15,000
- Gilbert Cisneros (D-CA31): Sale $1,001 - $15,000
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Results of operations and financial condition Nov 4, 2026
- Departure or appointment of directors or officers; Regulation FD disclosure Oct 28, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.